Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03758066 · ClinicalTrials.gov registry record · NA

PlusCare: Mobile Platform to Increase Linkage to Care in Adolescents Living With HIV/AIDS

A NA study of HIV/AIDS, sponsored by Dimagi.

Completed
Registry status
NA
Development phase
65
Enrollment target
1
Study location

NCT03758066 is a NA study of HIV/AIDS that has completed, run by Dimagi. The registered enrollment target is 65 participants, below the 33,180-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03758066, a NA study of HIV/AIDS, has completed, sponsored by Dimagi.

COMPLETED
Registry status
NA
Development phase
65 participants
Enrollment target
1
Study location

Study Summary

While major advancements in medical technology over the past decade have significantly improved the life expectancy of persons infected with human immunodeficiency virus (HIV), HIV-positive youth today face new barriers to the treatment of HIV as a chronic, manageable illness. The mobile system proposed will help improve linkage to care through mobile technology support for the case management of youth living with HIV. Results of this project will determine the impact of this system on case management processes and outcomes and have implications for the care of youth living with other chronic, complex illnesses.

Conditions Studied

Interventions

  • DEVICE PlusCare

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2019-01-02
Est. Completion 2020-12-31
Phase NA

Sponsor

Dimagi

4 total trials

What the Registry Record Tells You About NCT03758066

The ClinicalTrials.gov registry entry for NCT03758066 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 33,180-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower). The listed sponsor is Dimagi, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV/AIDS appearing as the primary indexed condition, and to 1 intervention - of which PlusCare is the first listed.

NCT03758066 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03758066 about?

NCT03758066 is a clinical study titled "PlusCare: Mobile Platform to Increase Linkage to Care in Adolescents Living With HIV/AIDS". While major advancements in medical technology over the past decade have significantly improved the life expectancy of persons infected with human immunodeficiency virus (HIV), HIV-positive youth today face new barriers to the treatment of HIV as a chronic, manageable illness. The mobile system prop...

What is the current status of trial NCT03758066?

This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2019-01-02. Estimated completion is 2020-12-31.

What conditions does trial NCT03758066 study?

This clinical trial studies the following conditions: HIV/AIDS.

What interventions are being tested in trial NCT03758066?

The interventions under investigation include: PlusCare (DEVICE).

Who is sponsoring clinical trial NCT03758066?

This trial is sponsored by Dimagi, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03758066 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV/AIDS

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.